1.63
price down icon12.37%   -0.23
after-market 시간 외 거래: 1.60 -0.03 -1.84%
loading

Phio Pharmaceuticals Corp 주식(PHIO)의 최신 뉴스

pulisher
10:51 AM

3 Penny Stocks to Watch Now, 11/4/25 - TipRanks

10:51 AM
pulisher
04:58 AM

Is Phio Pharmaceuticals Corp. stock in correction or buying zoneJuly 2025 PreEarnings & Weekly Breakout Opportunity Watchlist - newser.com

04:58 AM
pulisher
04:19 AM

How Phio Pharmaceuticals Corp. (44R1) stock reacts to fiscal policiesBull Run & Low Drawdown Investment Ideas - newser.com

04:19 AM
pulisher
03:57 AM

Best data tools to analyze Phio Pharmaceuticals Corp. stock2025 Earnings Impact & Weekly Top Gainers Trade List - newser.com

03:57 AM
pulisher
03:29 AM

Will Phio Pharmaceuticals Corp. stock outperform tech sector in 2025July 2025 Momentum & Weekly Market Pulse Alerts - newser.com

03:29 AM
pulisher
Nov 03, 2025

Can Phio Pharmaceuticals Corp. rally from current levelsMarket Weekly Review & Low Risk Growth Stock Ideas - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Phio Pharmaceuticals raises $13.4 million through warrant exercise By Investing.com - Investing.com Nigeria

Nov 03, 2025
pulisher
Nov 03, 2025

Can PHIO Bounce Back? - timothysykes.com

Nov 03, 2025
pulisher
Nov 03, 2025

Phio Pharmaceuticals Stock Falls 5% Amid Financing And Clinical Updates - Nasdaq

Nov 03, 2025
pulisher
Nov 03, 2025

Phio Pharmaceuticals raises $13.4 million through warrant exercise - Investing.com

Nov 03, 2025
pulisher
Nov 03, 2025

Phio Pharmaceuticals Announces Exercise of Warrants for Approximately $13.4 Million Gross Proceeds - Newsfile

Nov 03, 2025
pulisher
Nov 03, 2025

Why Is Phio Pharmaceuticals Stock Soaring Today? - Benzinga

Nov 03, 2025
pulisher
Nov 03, 2025

Why Is Phio Pharmaceuticals Stock Up 75% Today? - TipRanks

Nov 03, 2025
pulisher
Nov 03, 2025

Phio Pharmaceuticals Reports Positive Phase 1b Trial Results - TipRanks

Nov 03, 2025
pulisher
Nov 03, 2025

How Phio Pharmaceuticals Corp. stock benefits from tech adoptionChart Signals & AI Optimized Trading Strategy Guides - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Phio Pharmaceuticals Corp Announces Positive Results in Skin Cancer Trial - TradingView

Nov 03, 2025
pulisher
Nov 03, 2025

Phio Pharmaceuticals Announces Positive Pathology Results: Final Maximum Dose Cohort for INTASYL PH-762 Skin Cancer Trial - Newsfile

Nov 03, 2025
pulisher
Nov 03, 2025

Is Phio Pharmaceuticals Corp. stock attractive for retirement portfolios2025 Geopolitical Influence & Expert-Curated Trade Recommendations - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Phio Pharmaceuticals Corp. stock retracement – recovery analysisMarket Risk Report & Real-Time Volume Trigger Notifications - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How Phio Pharmaceuticals Corp. (44R1) stock reacts to new regulations2025 Price Momentum & Risk Managed Trade Strategies - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How currency fluctuations impact Phio Pharmaceuticals Corp. stockTrade Exit Report & Comprehensive Market Scan Insights - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Can Phio Pharmaceuticals Corp. hit a new high this month2025 Valuation Update & Fast Exit Strategy with Risk Control - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

Developing predictive dashboards with Phio Pharmaceuticals Corp. dataWeekly Trade Recap & AI Based Buy/Sell Signal Reports - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

What to do if you’re stuck in Phio Pharmaceuticals Corp.Quarterly Profit Report & Real-Time Buy Signal Notifications - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Top chart patterns to watch in Phio Pharmaceuticals Corp.Rate Cut & Technical Pattern Recognition Alerts - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Phio Pharmaceuticals appoints David Deming as lead independent director By Investing.com - Investing.com Australia

Nov 01, 2025
pulisher
Oct 31, 2025

What drives Phio Pharmaceuticals Corp 44R1 stock priceAnalyst Downgrades & Access Insider-Level Stock Analysis - earlytimes.in

Oct 31, 2025
pulisher
Oct 31, 2025

Phio Pharmaceuticals Corp. (PHIO) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK

Oct 31, 2025
pulisher
Oct 31, 2025

Phio Pharmaceuticals Appoints New Lead Independent Director - TipRanks

Oct 31, 2025
pulisher
Oct 31, 2025

Phio Pharmaceuticals Corp. Announces Appointment of David H. Deming as Lead Independent Director - MarketScreener

Oct 31, 2025
pulisher
Oct 31, 2025

[8-K] Phio Pharmaceuticals Corp. Reports Material Event | PHIO SEC FilingForm 8-K - Stock Titan

Oct 31, 2025
pulisher
Oct 31, 2025

Phio Pharmaceuticals appoints David Deming as lead independent director - Investing.com

Oct 31, 2025
pulisher
Oct 31, 2025

Phio Pharmaceuticals Announces Board Resignation - TradingView

Oct 31, 2025
pulisher
Oct 31, 2025

Phio Pharmaceuticals Announces Appointment of Mr. David H. Deming to the Position of Lead Independent Director - Newsfile

Oct 31, 2025
pulisher
Oct 31, 2025

Phio (NASDAQ: PHIO) names David H. Deming lead independent director, with over 30 years - Stock Titan

Oct 31, 2025
pulisher
Oct 31, 2025

Is Phio Pharmaceuticals Corp. stock supported by strong fundamentalsPortfolio Risk Summary & Free Growth Oriented Trading Recommendations - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Using economic indicators to assess Phio Pharmaceuticals Corp. potential2025 Top Decliners & Fast Gain Swing Trade Alerts - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Will Phio Pharmaceuticals Corp. stock rally after Fed decisionsShort Setup & Low Drawdown Momentum Ideas - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Is Phio Pharmaceuticals Corp. (44R1) stock included in top ETFsWeekly Loss Report & Weekly Watchlist of Top Performers - newser.com

Oct 31, 2025
$37.84
price up icon 1.45%
$28.76
price up icon 0.17%
$102.92
price up icon 1.33%
$104.83
price up icon 0.84%
biotechnology ONC
$309.19
price down icon 0.86%
$182.77
price down icon 1.86%
자본화:     |  볼륨(24시간):